US FDA declines to approve Corcept's drug for rare hormonal disorder

Corcept Therapeutics Incorporated

31/12/2025 13:04

Dec 31 (Reuters) - The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' CORT.O hormone-blocking drug for the treatment of a rare hormonal disorder, the company said on Wednesday.

 (Reporting by Sahil Pandey and Sneha S K in Bengaluru; Editing by Shailesh Kuber)

 ((Sahil.Pandey@thomsonreuters.com;))